Differential censoring in overall survival in phase 3 oncology clinical trials

Eric J Hsu, Alexander D Sherry, Timothy A Lin, Joseph Abi Jaoude, Ramez Kouzy, Zachary McCaw, Tomer Meirson, Pavlos Msaouel, Ethan B Ludmir

Open source

DOI
10.1093/jnci/djaf378
Published
2025-12-30
Container
JNCI: Journal of the National Cancer Institute
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djaf378,
  title = {Differential censoring in overall survival in phase 3 oncology clinical trials},
  author = {Eric J Hsu and Alexander D Sherry and Timothy A Lin and Joseph Abi Jaoude and Ramez Kouzy and Zachary McCaw and Tomer Meirson and Pavlos Msaouel and Ethan B Ludmir},
  year = {2025},
  journal = {JNCI: Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djaf378},
  url = {https://doi.org/10.1093/jnci/djaf378}
}

RIS

TY  - JOUR
TI  - Differential censoring in overall survival in phase 3 oncology clinical trials
AU  - Eric J Hsu
AU  - Alexander D Sherry
AU  - Timothy A Lin
AU  - Joseph Abi Jaoude
AU  - Ramez Kouzy
AU  - Zachary McCaw
AU  - Tomer Meirson
AU  - Pavlos Msaouel
AU  - Ethan B Ludmir
PY  - 2025
JO  - JNCI: Journal of the National Cancer Institute
DO  - 10.1093/jnci/djaf378
UR  - https://doi.org/10.1093/jnci/djaf378
ER  - 

APA

Hsu, E. J., Sherry, A. D., Lin, T. A., Jaoude, J. A., Kouzy, R., McCaw, Z., Meirson, T., Msaouel, P., & Ludmir, E. B. (2025). Differential censoring in overall survival in phase 3 oncology clinical trials. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf378

Source records